New developments in prion disease research

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Cell and Tissue Research

• Publication date

  2023-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00441-023-03760-yPMID 36918429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccines for prion diseases: a realistic goal?

  2023cited by this paper
• New developments in prion disease research using genetically modified mouse models

  2023cited by this paper
• Emergence of CWD strains

  2022cited by this paper
• Organoids for modeling prion diseases

  2022cited by this paper
• Role of sialylation of N-linked glycans in prion pathogenesis

  2022cited by this paper
• Prion disease modelled in Drosophila

  2022cited by this paper
• Cell biology of prion strains in vivo and in vitro

  2022cited by this paper
• Large animal models for chronic wasting disease

  2022cited by this paper
• Seed amplification and RT-QuIC assays to investigate protein seed structures and strains

  2022cited by this paper
• Gene expression and epigenetic markers of prion diseases

  2022cited by this paper
• Therapeutic development of polymers for prion disease

  2022cited by this paper
• Extracellular vesicles with diagnostic and therapeutic potential for prion diseases

  2022cited by this paper
• Prion-like strain effects in tauopathies

  2022cited by this paper
• Genetically engineered cellular models of prion propagation

  2022cited by this paper
• Non-human primates in prion diseases

  2022cited by this paper
• Lactose on the basolateral side of mammary epithelial cells inhibits milk production concomitantly with signal transducer and activator of transcription 5 inactivation

  2022cited by this paper
• Prion strains: shining new light on old concepts

  2022cited by this paper
• Cholesterol and its reciprocal association with prion infection

  2022cited by this paper
• Prion strains viewed through the lens of cryo-EM

  2022cited by this paper
• Mechanisms of prion-induced toxicity

  2022cited by this paper
• Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier

  2022cited by this paper
• Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease

  2022cited by this paper
• PMCA for ultrasensitive detection of prions and to study disease biology

  2022cited by this paper
• Therapeutic strategies for identifying small molecules against prion diseases

  2022cited by this paper
• RT-QuIC as ultrasensitive method for prion detection

  2022cited by this paper
• Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein

  2022cited by this paper
• From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases

  2021cited by this paper
• Disulfide-crosslink scanning reveals prion–induced conformational changes and prion strain–specific structures of the pathological prion protein PrPSc

  2018cited by this paper
• Extracellular Vesicles

  2017cited by this paper
• Prions on the move

  2011cited by this paper
• Molecular pathology of human prion disease

  2010cited by this paper
• A molecular switch controls interspecies prion disease transmission in mice.

  2010cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• The yeast Sup35NM domain propagates as a prion in mammalian cells

  2009cited by this paper
• Prion agent diversity and species barrier.

  2008cited by this paper
• A General Model of Prion Strains and Their Pathogenicity

  2007cited by this paper
• Molecular basis of cerebral neurodegeneration in prion diseases

  2007cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• Neuropathology of prion diseases.

  2003cited by this paper
• Strain variations and species barriers.

  2001cited by this paper
• Nobel Lecture: Prions

  1998cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent

  1992cited by this paper
• Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

  1990cited by this paper
• Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.

  1989cited by this paper
• Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.

  1973cited by this paper

• Physiology of Cellular Prion Proteins in Reproduction

  2024cites this paper
• Roles of prion proteins in mammalian development

  2024cites this paper